HU912821D0 - Process for producing thienotriazolo (or imidazolo) diazepine amides and pharmaceutical compositions comprising same - Google Patents

Process for producing thienotriazolo (or imidazolo) diazepine amides and pharmaceutical compositions comprising same

Info

Publication number
HU912821D0
HU912821D0 HU912821A HU282191A HU912821D0 HU 912821 D0 HU912821 D0 HU 912821D0 HU 912821 A HU912821 A HU 912821A HU 282191 A HU282191 A HU 282191A HU 912821 D0 HU912821 D0 HU 912821D0
Authority
HU
Hungary
Prior art keywords
thienotriazolo
imidazolo
diazepine
amides
producing
Prior art date
Application number
HU912821A
Other languages
English (en)
Other versions
HUT62007A (en
Inventor
Karl-Heinz Dr Weber
Werner Dr Stransky
Ulrike Dr Kuefner-Muehl
Hubert Dr Heuer
Franz Dr Birke
Wolf-Dietrich Dr Bechtel
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of HUT62007A publication Critical patent/HUT62007A/hu
Publication of HU912821D0 publication Critical patent/HU912821D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU912821A 1990-08-30 1991-08-29 Process for producing thienotriazolo (or imidazolo) diazepine amides and pharmaceutical compositions comprising same HU912821D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4027470A DE4027470A1 (de) 1990-08-30 1990-08-30 Neue hetrazepinoide amide

Publications (2)

Publication Number Publication Date
HUT62007A HUT62007A (en) 1993-03-29
HU912821D0 true HU912821D0 (en) 1993-03-29

Family

ID=6413254

Family Applications (1)

Application Number Title Priority Date Filing Date
HU912821A HU912821D0 (en) 1990-08-30 1991-08-29 Process for producing thienotriazolo (or imidazolo) diazepine amides and pharmaceutical compositions comprising same

Country Status (17)

Country Link
US (1) US5698552A (hu)
EP (1) EP0475204A3 (hu)
JP (1) JPH04261181A (hu)
KR (1) KR920004394A (hu)
AU (1) AU8346291A (hu)
CA (1) CA2050268A1 (hu)
CS (1) CS265391A3 (hu)
DE (1) DE4027470A1 (hu)
FI (1) FI914071A (hu)
HU (1) HU912821D0 (hu)
IE (1) IE913043A1 (hu)
IL (1) IL99325A0 (hu)
MX (1) MX9100845A (hu)
NO (1) NO913391L (hu)
PL (1) PL291562A1 (hu)
PT (1) PT98816B (hu)
ZA (1) ZA916902B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656004A1 (en) * 1992-08-20 1995-06-07 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US5821924A (en) * 1992-09-04 1998-10-13 Elonex I.P. Holdings, Ltd. Computer peripherals low-power-consumption standby system
US5389952A (en) * 1992-12-02 1995-02-14 Cordata Inc. Low-power-consumption monitor standby system
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
EP0989131B1 (en) * 1996-09-13 2002-11-13 Mitsubishi Pharma Corporation Thienotriazolodiazepine compounds and medicinal uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TR201906788T4 (tr) 2014-06-20 2019-05-21 Constellation Pharmaceuticals Inc 2-((4s)-6-(4-klorofenil)-1-metil-4h-benzo[c]izoksazolo[4,5-e]azepın-4-il)asetamidin kristal formları.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
FI95708C (fi) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
EP0368175A1 (de) * 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
DE3909012A1 (de) * 1989-03-18 1990-09-20 Boehringer Ingelheim Kg Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
YU133090A (sh) * 1989-07-12 1993-10-20 Boehringer Ingelheim Kg. Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine

Also Published As

Publication number Publication date
DE4027470A1 (de) 1992-03-05
IL99325A0 (en) 1992-07-15
HUT62007A (en) 1993-03-29
MX9100845A (es) 1992-04-01
US5698552A (en) 1997-12-16
AU8346291A (en) 1992-03-05
KR920004394A (ko) 1992-03-27
FI914071A (fi) 1992-03-01
CA2050268A1 (en) 1992-03-01
NO913391D0 (no) 1991-08-29
FI914071A0 (fi) 1991-08-29
NO913391L (no) 1992-03-02
PT98816B (pt) 1999-01-29
PT98816A (pt) 1992-07-31
EP0475204A3 (en) 1992-05-13
ZA916902B (en) 1992-04-29
PL291562A1 (en) 1992-10-05
EP0475204A2 (de) 1992-03-18
IE913043A1 (en) 1992-03-11
CS265391A3 (en) 1992-03-18
JPH04261181A (ja) 1992-09-17

Similar Documents

Publication Publication Date Title
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT62559A (en) Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same
HU9301879D0 (en) Process and compositions for disinfecting contact-lenses
HUT59677A (en) Process for producing indol- and benzimidazol-substituted imidazol deivatives and pharmaceutical compositions containing them
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
HUT67375A (en) 1,5-benzodiazepine derivatives, pharmaceutical compositions containing them and process for their producing
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUT63859A (en) Process for producing cyclopeptides and pharmaceutical compositions comprising same
HUT60488A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions comprising same
EP0525530A3 (en) Perfume samplers and process for their manufacture
HUT61731A (en) Process for producing glycinamide derivatives and pharmaceutical compositions comprising same
HU912821D0 (en) Process for producing thienotriazolo (or imidazolo) diazepine amides and pharmaceutical compositions comprising same
HUT64059A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
HU216713B (hu) Ciklusos acetálok és eljárás az előállításukra
HUT61548A (en) Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
ZA911927B (en) Labdanes and process for their preparation
HUT63162A (en) Process for producing 1,4-benzodiazepine derivatives and pharmaceutical compositions comprising same
HU9301104D0 (en) Method for producing tetrahydro-indeno-indole derivatves and pharmaceutical preparatives containing it
HUT53635A (en) Process for producing benzazepine and benzothiazepine derivatives and pharmaceutical compositions comprising same
HUT63629A (en) Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same
HUT59922A (en) Process for producing 1-azabicycloalkane derivatives and pharmaceutical compositions containing them
HUT59154A (en) Process for producing 6-methyl-19-norsteroids and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment
DFC4 Cancellation of temporary protection due to refusal